Shares of NantKwest Inc. (NK) are rising over 48% in pre-market today, after the company announced that NantKwest and ImmunityBio Inc. are in active discussions with the U.S. Food and Drug Administration (FDA) for vaccines and therapeutics to combat COVID-19.
from RTT - Before the Bell https://ift.tt/2K6ClLH
via IFTTT
No comments:
Post a Comment